Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Memory Reconsolidation Blockade for Treating Drug Addiction: a Feasibility Study

NCT01634347 is registered in ClinicalTrials.gov with Douglas Mental Health University Institute as lead sponsor.

NCT NCT01634347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01634347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Memory Reconsolidation Blockade for Treating Drug Addiction: a Feasibility Study
Lead sponsor
Douglas Mental Health University Institute
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2012
Completion date
May 31, 2014
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

substance dependence